#United States #New York #Class Action #Pomerantz LLP #LifeMD

Pomerantz Law Firm's Investor Alert on LifeMD, Inc.

Pomerantz LLP, a renowned law firm specializing in class action lawsuits, has made headlines with its announcement of a class action lawsuit against LifeMD, Inc. (Nasdaq: LFMD). This legal action particularly targets investors who have suffered losses related to their investments in LifeMD. As the deadline approaches, affected investors are urged to act quickly.

Overview of the Class Action

Investors are reminded that they have until October 27, 2025, to request the Court to appoint them as Lead Plaintiff in the class action. Those who purchased or otherwise acquired LifeMD securities during the defined Class Period are crucial to this process. Interested parties can reach out to attorney Danielle Peyton at [email protected] or call 646-581-9980 (toll-free number: 888.4-POMLAW, Ext. 7980). For your convenience, it’s encouraged to provide your contact details, including your mailing address and the total number of shares acquired, to streamline the process.

The lawsuit revolves around allegations that LifeMD and several of its officers and/or directors may have engaged in practices that resulted in securities fraud. Specifically, this highlights concerns about potential unlawful business practices, prompting the firm to take legal action to protect the rights of investors.

Impact of Recent Press Releases

On August 5, 2025, LifeMD released its second-quarter results, which indicated some unexpected challenges facing its Rex MD business. CFO Marc Benathen stated that these issues are largely resolved; however, the company is still revising its full-year 2025 revenue and adjusted EBITDA guidance downward. According to Benathen, while these challenges will impact the company's performance, they still expect to see significant growth year-over-year in revenue and EBITDA metrics.

Notably, the announcement led to a dramatic decline in LifeMD's stock price, plummeting 44.85%, which translates to a drop of $5.31 per share, settling at $6.53 on August 6, 2025. This sharp decline has raised significant alarm among investors, underscoring the seriousness of the allegations presented in the class action lawsuit.

About Pomerantz LLP

For over 85 years, Pomerantz LLP has established a reputation as a leader in corporate, securities, and antitrust class litigation. Founded by Abraham L. Pomerantz, a pioneer known for his work in securities class actions, the firm has championed the rights of those affected by securities fraud, corporate misconduct, and breaches of fiduciary duty. Pomerantz continues to uphold its legacy by seeking substantial damages on behalf of class members affected by corporate negligence.

Get Involved

If you believe you’ve been impacted by LifeMD’s recent actions, do not hesitate to contact Pomerantz LLP. They remain committed to advocating for investors and preserving their rights in the face of corporate misconduct. For more detailed information on joining the class action or to access the full complaint, visit their official site at www.pomerantzlaw.com.

By staying proactive during this period, investors can ensure they are termed as lead plaintiffs and have their voices amplified in court. As the legal landscape evolves, timely action will be critical for investors looking to protect their interests in LifeMD, Inc.

Conclusion

The filing of this class action lawsuit against LifeMD, Inc. highlights ongoing concerns within the investment community regarding corporate conduct and transparency. As more investors become aware of potential securities fraud, it becomes increasingly important to remain informed and vigilant. Pomerantz LLP is here to assist affected investors in navigating this complex legal terrain with expert guidance and advocacy.

Stay tuned for further developments on this case, and don’t overlook the importance of acting quickly to protect your investment interests.